Kansas City

Integrated Kidney Partners XXIII LLC

Primary Contact

Ryan Pardo
Ryan.Pardo@usrenalcare.com


KCE Participants


Practices

Kansas City Kidney Consultants PA

Ahmed Awad Rachel Luber
Barry Wood Kyrstin Alexander
Emily Johnston Ryan Lustig
Gretchen Casper Ashley Arrowood
Irme Akhtar Brandon Calhoun
Molly Cahill Suzanne Cummings
Rafael Torosyan Tamika Clark

Nephrology Associates MD PA

Achal Desai Roberta Mott
Anne Spade Archana Goel
Catherine Moss Connie Roe
Venu Nair Heather Conklin
James Redington Justin Teiwes
Kamal Hatahet Deanna Campbell
Kristine Herron Michael Lambert
Najindra Maharjan Richard Schumacher
Suganthi Beeki Suleiman Daifallah
Tessa Weigel

Kidney Associates of Kansas City PC

Ahmed Al-Absi Amber Mcgee
Glory Chukwusom Karid Nieves-Borrero
Mohammed Mohialdeen Andrew Beisser
Nicole Romine Pranavkumar Dalal
Richard Muther Kelly Alford

Wichita Nephrology Group, PA

Amanda Valliant Edgard Wehbe
Erica Roach Jany Moussa
Joseph Meouchy Levi Short
Michael Grant Mohamad Sandid
Ronnie Moussa Shawna Abendroth
Tracy Smith Wissam Saliba

Mogilishetty PLLC

Gautham Mogilishetty

Preferred Providers

Practice Provider Name
Advent Medical Group LLC
Heart Centered Counseling PC
Psycare Inc
Psychiatric and Counseling Associates LLC
Psychological & Behavioral Consultants LLC
Rocky Mountain Kidney Care LLC Chandel Baty
Jourdan Heitschmidt
Stefanie Neill

Joint Ventures

There are no joint ventures between or among the KCE and any of its KCE Participants and Preferred Providers.


Administrative Lead

Name Employer
Alan St. Pierre KidneyLink

Clinical Lead

Name Employer
Dr. Ryan Lustig Kansas City Kidney Consultants

KCE Governing Body Members

Name Employer
Ryan Lustig Kansas City Kidney Consultants PA
Gautham Mogilishetty Mogilishetty PLLC
Richard Schumacher Nephrology Associates MD PA
Alan St. Pierre KidneyLink
Lori Hartwell Renal Support Group

Shared Savings and Shared Losses Information

a. Gross Savings/Losses BEFORE CMS withholds:
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $6,676,462

b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation:
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $2,483,194

c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 100%

d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: N/A

8. The KCE’s performance on the quality measures used to calculate the KCE’s TQS, as described in the Quality Overview Document and Measure Specifications Document.
Total Quality Score (TQS) results out of 100%, based on KCE quality measure performance during the period
Performance Year 2023 TQS: 50%
Performance Year 2024 TQS: 86.25%

9. Total Program Income to Participants (QCP, Transplant Bonus, Home Bonus, other income)
PY2023 Ancillary Income will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $1,487,126